Home / 4171.TWO : TWO

AI Analysis Fundamentals Valuation Video Analysis Similar

AI Analysis

How does 4171.TWO make money? Does 4171.TWO have pricing power? What's the Earnings Whisper? Will 4171.TWO profit more as the business scales? What is 4171.TWO's management track record? Is 4171.TWO's current price justified?

GeneReach Biotechnology Corp.

TWD 16.3 -$2.50 (-13.30%)

TWO · 16 Sep 2026 05:30 UTC

Previous Close

TWD 16.15

Day Range

TWD 16.25TWD 16.9

Year Range

TWD 16.05TWD 26.9

Market Cap

934.03M

AVG Volume

168.47K

Trailing/Forward PE

-21.58/9.65

PEG ratio

-0.15

Dividend Yield

Next Earnings Date

Primary Exchange

Taipei Exchange

Revenue (TWD)

4171.TWO Revenue (TWD) by quarter
Period	Revenue (TWD)
26 Q2	60.02M
26 Q1	52.28M
25 Q4	72.38M
25 Q3	53.39M
25 Q2	54.5M
25 Q1	52.47M
24 Q4	54.97M
24 Q3	62.46M
24 Q2	43.16M
24 Q1	45.91M

Net Income (TWD)

4171.TWO Net Income (TWD) by quarter
Period	Net Income (TWD)
26 Q2	-3.88M
26 Q1	-5.37M
25 Q4	2.29M
25 Q3	-36.62M
25 Q2	-66.11M
25 Q1	-10.34M
24 Q4	-35.4M
24 Q3	-26.89M
24 Q2	-36.18M
24 Q1	-20.26M

Operating Income (TWD)

4171.TWO Operating Income (TWD) by quarter
Period	Operating Income (TWD)
26 Q2	-8.45M
26 Q1	-14.09M
25 Q4	27.59M
25 Q3	-24.93M
25 Q2	-25.99M
25 Q1	-25.9M
24 Q4	-26.92M
24 Q3	-26.66M
24 Q2	-34.77M
24 Q1	-23.59M

EBITDA (TWD)

4171.TWO EBITDA (TWD) by quarter
Period	EBITDA (TWD)
26 Q2	5.16M
26 Q1	178K
25 Q4	27.59M
25 Q3	-18.33M
25 Q2	-43.77M
25 Q1	7.48M
24 Q4	-9.77M
24 Q3	-8.25M
24 Q2	-16.77M
24 Q1	-1.51M

Cash Flows (TWD)

4171.TWO Cash Flows (TWD) by quarter
Period	Cash Flows (TWD)
26 Q2	-5.54M
26 Q1	57K
25 Q4	10.21M
25 Q3	-4.54M
25 Q2	-24.28M
25 Q1	-3.8M
24 Q4	-7.06M
24 Q3	-11.35M
24 Q2	-10.64M
24 Q1	-2.64M

EPS (TWD)

4171.TWO EPS (TWD) by quarter
Period	EPS (TWD)
26 Q2	-0.07
26 Q1	-0.09
25 Q4	0.05
25 Q3	-0.65
25 Q2	-1.16
25 Q1	-0.18
24 Q4	-0.62
24 Q3	-0.47
24 Q2	-0.63
24 Q1	-0.35

Expenses (TWD)

4171.TWO Expenses (TWD) by quarter
Period	Expenses (TWD)
26 Q2	57.34M
26 Q1	44.66M
25 Q4	52.54M
25 Q3	61.16M
25 Q2	67.84M
25 Q1	62.48M
24 Q4	65.47M
24 Q3	64.11M
24 Q2	61.81M
24 Q1	71.22M

Cash & Debt (TWD)

4171.TWO Cash & Debt (TWD) by quarter
Period	Cash & Debt (TWD)
26 Q2	395.82M
26 Q1	405.94M
25 Q4	404.76M
25 Q3	397.35M
25 Q2	440.41M
25 Q1	491.73M
24 Q4	503.76M
24 Q3	519.64M
24 Q2	518.24M
24 Q1	567.47M

Debt ratios

4171.TWO Debt ratios by quarter
Period	Debt ratios
26 Q2	-12.02
26 Q1	5.46
25 Q4	6.64
25 Q3	2.65
25 Q2	3.22
25 Q1	8.14
24 Q4	6.36
24 Q3	2.09
24 Q2	1.68
24 Q1	2.18

Margins

4171.TWO Margins by quarter
Period	Margins
26 Q2	80.33%
26 Q1	71.8%
25 Q4	73.67%
25 Q3	64.07%
25 Q2	73.45%
25 Q1	63.58%
24 Q4	67.67%
24 Q3	56.47%
24 Q2	58.72%
24 Q1	44.59%

Return on Capital

4171.TWO Return on Capital by quarter
Period	Return on Capital
26 Q2	-0.67%
26 Q1	-0.91%
25 Q4	0.38%
25 Q3	-6.19%
25 Q2	-10.58%
25 Q1	-1.44%
24 Q4	-4.88%
24 Q3	-3.53%
24 Q2	-4.48%
24 Q1	-2.4%

Shares Outstanding

4171.TWO Shares Outstanding by quarter
Period	Shares Outstanding
26 Q2	59.52M
26 Q1	59.71M
25 Q4	55.81M
25 Q3	56.34M
25 Q2	56.99M
25 Q1	57.42M
24 Q4	57.46M
24 Q3	57.22M
24 Q2	57.43M
24 Q1	57.89M

Dividends (TWD)

4171.TWO Dividends (TWD) by quarter
Period	Dividends (TWD)
Jul 23	1.5
Sep 22	4
Oct 21	2.57

Book Value Per Share (TWD)

4171.TWO Book Value Per Share (TWD) by quarter
Period	Book Value Per Share (TWD)
26 Q2	9.77
26 Q1	9.93
25 Q4	10.69
25 Q3	10.5
25 Q2	10.96
25 Q1	12.46
24 Q4	12.63
24 Q3	13.3
24 Q2	14.05
24 Q1	14.57

Total Assets (TWD)

4171.TWO Total Assets (TWD) by quarter
Period	Total Assets (TWD)
26 Q2	858.12M
26 Q1	864.6M
25 Q4	881.05M
25 Q3	877.51M
25 Q2	947.03M
25 Q1	1.05B
24 Q4	1.07B
24 Q3	1.09B
24 Q2	1.19B
24 Q1	1.19B

Free Cash Flow Yield

4171.TWO Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-1.92%
Sep 26	-1.91%
Sep 26	-1.85%
Aug 26	-1.81%
Aug 26	-1.8%
Aug 26	-1.82%
Aug 26	-1.82%
Jul 26	-1.79%
Jul 26	-1.64%
Jul 26	-1.69%
Jul 26	-1.82%
Jul 26	-1.8%
Jun 26	-2.37%
Jun 26	-2.32%
Jun 26	-2.3%
Jun 26	-2.23%
May 26	-2.26%
May 26	-2.23%
May 26	-2.26%
May 26	-2.17%
Apr 26	-2.09%
Apr 26	-2.01%
Apr 26	-2.04%
Apr 26	-2.16%
Apr 26	-2.12%
Mar 26	-3.79%
Mar 26	-3.72%
Mar 26	-3.71%
Mar 26	-3.48%
Feb 26	-3.46%
Feb 26	-3.44%
Feb 26	-3.34%
Jan 26	-3.22%
Jan 26	-3.33%
Jan 26	-3.58%
Jan 26	-3.51%
Jan 26	-3.72%
Dec 25	-4.18%
Dec 25	-4.16%
Dec 25	-3.88%
Dec 25	-4.25%
Nov 25	-4.07%
Nov 25	-4.25%
Nov 25	-4.07%
Nov 25	-3.73%
Oct 25	-3.3%
Oct 25	-3.94%
Oct 25	-4.78%
Oct 25	-4.65%
Oct 25	-4.66%
Sep 25	-3.16%
Sep 25	-3.13%
Sep 25	-3.08%
Sep 25	-2.93%
Aug 25	-2.93%
Aug 25	-2.87%
Aug 25	-2.86%
Aug 25	-2.83%
Aug 25	-2.95%
Jul 25	-2.85%
Jul 25	-2.74%
Jul 25	-2.83%
Jul 25	-2.79%
Jun 25	-2.63%
Jun 25	-2.6%
Jun 25	-2.35%
Jun 25	-2.3%
May 25	-2.32%
May 25	-2.51%
May 25	-2.6%
May 25	-2.79%
May 25	-2.69%
Apr 25	-3%
Apr 25	-3%
Apr 25	-3.23%
Apr 25	-2.42%
Mar 25	-3.55%
Mar 25	-3.31%
Mar 25	-3.25%
Mar 25	-3.25%
Feb 25	-3.1%
Feb 25	-3.11%
Feb 25	-3.18%
Feb 25	-3.1%
Jan 25	-3.14%
Jan 25	-3.12%
Jan 25	-2.96%
Jan 25	-3.13%
Dec 24	-1.97%
Dec 24	-2.13%
Dec 24	-2.17%
Dec 24	-2.01%
Nov 24	-2.01%
Nov 24	-2.01%
Nov 24	-2.03%
Nov 24	-1.94%
Nov 24	-1.99%
Oct 24	-1.98%
Oct 24	-2.02%
Oct 24	-1.97%

Price to Sales

4171.TWO Price to Sales by quarter
Period	Price to Sales
Sep 26	4.15
Sep 26	4.19
Sep 26	4.31
Aug 26	4.4
Aug 26	4.43
Aug 26	4.38
Aug 26	4.38
Jul 26	4.45
Jul 26	4.88
Jul 26	4.72
Jul 26	4.39
Jul 26	4.43
Jun 26	4.06
Jun 26	4.15
Jun 26	4.18
Jun 26	4.32
May 26	4.26
May 26	4.33
May 26	4.26
May 26	4.45
Apr 26	4.6
Apr 26	4.8
Apr 26	4.72
Apr 26	4.46
Apr 26	4.53
Mar 26	4.87
Mar 26	4.96
Mar 26	4.97
Mar 26	5.3
Feb 26	5.32
Feb 26	5.36
Feb 26	5.52
Jan 26	5.72
Jan 26	5.53
Jan 26	5.15
Jan 26	5.25
Jan 26	4.96
Dec 25	4.95
Dec 25	4.98
Dec 25	5.33
Dec 25	4.88
Nov 25	5.09
Nov 25	4.88
Nov 25	5.09
Nov 25	5.55
Oct 25	6.29
Oct 25	5.26
Oct 25	4.33
Oct 25	4.46
Oct 25	4.44
Sep 25	4.88
Sep 25	4.92
Sep 25	5
Sep 25	5.26
Aug 25	5.26
Aug 25	5.38
Aug 25	5.39
Aug 25	5.44
Aug 25	5.23
Jul 25	5.42
Jul 25	5.63
Jul 25	5.46
Jul 25	5.53
Jun 25	5.84
Jun 25	5.91
Jun 25	6.54
Jun 25	6.68
May 25	6.62
May 25	6.12
May 25	5.9
May 25	5.51
May 25	5.7
Apr 25	5.12
Apr 25	5.12
Apr 25	4.76
Apr 25	6.34
Mar 25	6.79
Mar 25	7.28
Mar 25	7.4
Mar 25	7.4
Feb 25	7.78
Feb 25	7.75
Feb 25	7.57
Feb 25	7.76
Jan 25	7.68
Jan 25	7.72
Jan 25	8.14
Jan 25	7.71
Dec 24	8.79
Dec 24	8.13
Dec 24	8
Dec 24	8.63
Nov 24	8.64
Nov 24	8.63
Nov 24	8.55
Nov 24	8.91
Nov 24	8.69
Oct 24	8.73
Oct 24	8.58
Oct 24	8.79

Price/Operating Cashflow

4171.TWO Price/Operating Cashflow by quarter
Period	Price/Operating Cashflow
Sep 24	298.2
Sep 24	305.39
Sep 24	303.48
Sep 24	315.94
Aug 24	324.09
Aug 24	304.43
Aug 24	296.76
Aug 24	295.8
Aug 24	301.08
Jul 24	315.94
Jul 24	325.53
Jul 24	325.05
Jul 24	347.1
Mar 24	158.35
Mar 24	161.71
Mar 24	164.83
Mar 24	171.07
Mar 24	183.31
Feb 24	181.87
Feb 24	188.59
Feb 24	178.99
Feb 24	183.31
Jan 24	178.03
Jan 24	179.47
Jan 24	184.75
Jan 24	190.98
Dec 23	189.31

Price to Book

4171.TWO Price to Book by quarter
Period	Price to Book
Sep 26	1.63
Sep 26	1.64
Sep 26	1.69
Aug 26	1.73
Aug 26	1.74
Aug 26	1.72
Aug 26	1.72
Jul 26	1.75
Jul 26	1.91
Jul 26	1.85
Jul 26	1.72
Jul 26	1.74
Jun 26	1.59
Jun 26	1.62
Jun 26	1.63
Jun 26	1.68
May 26	1.66
May 26	1.69
May 26	1.66
May 26	1.74
Apr 26	1.8
Apr 26	1.87
Apr 26	1.84
Apr 26	1.74
Apr 26	1.77
Mar 26	1.77
Mar 26	1.8
Mar 26	1.81
Mar 26	1.93
Feb 26	1.94
Feb 26	1.95
Feb 26	2.01
Jan 26	2.08
Jan 26	2.01
Jan 26	1.88
Jan 26	1.91
Jan 26	1.8
Dec 25	1.78
Dec 25	1.79
Dec 25	1.92
Dec 25	1.75
Nov 25	1.83
Nov 25	1.75
Nov 25	1.83
Nov 25	1.99
Oct 25	2.26
Oct 25	1.89
Oct 25	1.56
Oct 25	1.6
Oct 25	1.6
Sep 25	1.45
Sep 25	1.46
Sep 25	1.49
Sep 25	1.57
Aug 25	1.57
Aug 25	1.6
Aug 25	1.61
Aug 25	1.62
Aug 25	1.56
Jul 25	1.61
Jul 25	1.68
Jul 25	1.63
Jul 25	1.65
Jun 25	1.66
Jun 25	1.68
Jun 25	1.86
Jun 25	1.9
May 25	1.88
May 25	1.74
May 25	1.68
May 25	1.57
May 25	1.62
Apr 25	1.46
Apr 25	1.46
Apr 25	1.35
Apr 25	1.81
Mar 25	1.84
Mar 25	1.97
Mar 25	2.01
Mar 25	2.01
Feb 25	2.11
Feb 25	2.1
Feb 25	2.05
Feb 25	2.1
Jan 25	2.08
Jan 25	2.09
Jan 25	2.21
Jan 25	2.09
Dec 24	2.09
Dec 24	1.94
Dec 24	1.9
Dec 24	2.05
Nov 24	2.06
Nov 24	2.05
Nov 24	2.04
Nov 24	2.12
Nov 24	2.07
Oct 24	2.08
Oct 24	2.04
Oct 24	2.09

No video analysis for this stock yet. Request one from our team.

AI Analysis

GeneReach Biotechnology Corp.

Video analysis: 4171.TWO

Similar companies